Your browser doesn't support javascript.
loading
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis.
D'Angelo, Christopher R; Hanel, Walter; Chen, Yi; Yu, Menggang; Yang, David; Guo, Ling; Karmali, Reem; Burkart, Madelyn; Ciccosanti, Colleen; David, Kevin; Risch, Zachary; Murga-Zamalloa, Carlos; Devata, Sumana; Wilcox, Ryan; Savani, Malvi; Courville, Elizabeth L; Bachanova, Veronika; Rabinovich, Emma; Peace, David; Osman, Fauzia; Epperla, Narendranath; Kenkre, Vaishalee P.
Afiliação
  • D'Angelo CR; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Hanel W; Department of Internal Medicine, Division of Hematology/Oncology, The Ohio State University Hospital, Columbus, Ohio, USA.
  • Chen Y; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Yu M; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Yang D; Department of Pathology, University of Wisconsin Carbone Cancer Center Madison, Wisconsin, USA.
  • Guo L; The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Karmali R; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Burkart M; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Ciccosanti C; Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • David K; Division of Hematology/Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
  • Risch Z; The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Murga-Zamalloa C; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Devata S; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Wilcox R; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.
  • Savani M; Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, Arizona, USA.
  • Courville EL; Department of Pathology, University of Virginia, Charlottesville, Virginia, USA.
  • Bachanova V; Department of Internal Medicine, Division of Hematology/Oncology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Rabinovich E; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Peace D; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Osman F; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Epperla N; The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Kenkre VP; Department of Pathology, University of Wisconsin Carbone Cancer Center Madison, Wisconsin, USA.
Hematol Oncol ; 39(4): 473-482, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34347909

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido